United States· US:85766-030_4a16aad9-d46e-bf19-e063-6394a90a0326
celecoxib
A medicinal product containing celecoxib, registered in United States by Sportpharm LLC.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CELECOXIB
- Manufacturer
- Sportpharm LLC
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 18
- ndc118576603000100 CAPSULE in 1 BOTTLE (85766-030-00)
- ndc1185766030011 CAPSULE in 1 BOTTLE (85766-030-01)
- ndc1185766030077 CAPSULE in 1 BOTTLE (85766-030-07)
- ndc11857660301010 CAPSULE in 1 BOTTLE (85766-030-10)
- ndc11857660301414 CAPSULE in 1 BOTTLE (85766-030-14)
- ndc11857660302020 CAPSULE in 1 BOTTLE (85766-030-20)
- ndc11857660303030 CAPSULE in 1 BOTTLE (85766-030-30)
- ndc11857660306060 CAPSULE in 1 BOTTLE (85766-030-60)
- ndc11857660309090 CAPSULE in 1 BOTTLE (85766-030-90)
- ndc1185766-030-00
- ndc1185766-030-01
- ndc1185766-030-07
- ndc1185766-030-10
- ndc1185766-030-14
- ndc1185766-030-20
- ndc1185766-030-30
- ndc1185766-030-60
- ndc1185766-030-90
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Celecoxib in 16 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandOnsenalPfizer Limited
- United KingdomOnsenal 400mg capsulesPfizer Ltd
- CzechiaACLEXAKrka, d.d., Novo mesto, Novo mesto
- SpainARTILOG 100 mg CAPSULAS DURASPfizer Gep S.L.
- CanadaAG-CELECOXIBANGITA PHARMA INC.
- SwitzerlandCelebrex
- FranceCELEBREX 100 mg, géluleVIATRIS UP
- BelgiumCelebrex 100 mgViatris Healthcare
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Celebrex, Celecoxib Ratiopharm
- Belgium · Celebrex, Celecoxib Ab
- Bulgaria · Аклекса, Дефинакс
- Cyprus · Celebrex, Celecoxib Accord
- Czechia · Aclexa, Celebrex
- Germany · Celebrex, Celecaxiro
- Denmark · Celebra, Celecoxib Accord
- Estonia · Aclexa, Celebrex
- Spain · Artilog, Axatal
- Finland · Celebra, Celecoxib Krka
- France · Celebrex, Celecoxib Arrow Lab
- United Kingdom (Northern Ireland) · Celebrex, Celecoxib
- Greece · Celebrex
- Croatia · Aclexa, Celixib
- Hungary · Aclexa, Celebrex
- Ireland · Celebrex, Celecoxib Accord Healthcare Ireland
- Iceland · Celebra, Celecoxib Actavis
- Italy · Celartrox, Celebrex
- Lithuania · Aclexa, Celecoxib Accord
- Luxembourg · Celebrex, Celecoxib Eg
- Latvia · Celebrex, Celecoxib Inteli
- Malta · Aclexa, Celebrex
- Netherlands · Bixocel, Celebrex
- Norway · Celebra, Celecoxib Accord
- Poland · Aclexa, Celebrex
- Portugal · Celebrex, Celecoxib Alter
- Romania · Aclexa, Capsule Teva
- Sweden · Celebra, Celecoxib Accord
- Slovenia · Aclexa, Celebrex
- Slovakia · Aclexa, Celebrex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e2ac7871-d8cc-4b8c-a32a-2fb895d2eaa1 GET /v1/drugs/e2ac7871-d8cc-4b8c-a32a-2fb895d2eaa1?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "400",
"substance": "CELECOXIB",
"productndc": "85766-030",
"dosage_form": "CAPSULE",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA204590",
"marketing_category": "ANDA"
}See everything about celecoxib.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.